Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durv... Read More
Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'TulmiSTAR-01: A two-part, Phase I dose escalation and expansion followed by a randomized, open-labe... Read More
Singapore, May 14 -- The Health Sciences Authority received information related to the study titled 'A Master Protocol of an Open-Label, Multi-Drug, Multi-Centre, Phase II Study to Evaluate the Safety... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584590) titled 'A Brief Intervention by Nurses to Reduce the Prescribing of Occluded Peripheral Venous Cathe... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583589) titled 'Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584083) titled 'Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)' on May 07. Br... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583069) titled 'Psychosocial Effects of a Trauma-Informed Artificial Intelligence-Supported Chatbot in Adult... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583537) titled 'Augmented Reality and 3D Model-Based Ventrogluteal Injection Training in Nursing Students (A... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07583277) titled 'Selective Dorsal Rhizotomy as a Cost Effective and Safe Procedure as a Alternative to Intrat... Read More
U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584902) titled 'A 2x2 Factorial Randomized Controlled Trial for ERCP' on March 24. Brief Summary: To invest... Read More